Research Units

New Modality Unit

New Modality (NM) unit has started its operation from October 2018. In addition to accelerating drug discovery using its proprietary antibody technologies, Chugai Pharmaceutical Co., Ltd. (Chugai) has been working to establish New Modality discovery technologies as candidates for its next-generation core technology for more than a decade. Chugai has decided to transfer into CPR this discovery technology with researchers who possess industry-leading research and technological capabilities backed by both chemistry and biotechnology. The NM unit researchers has been concentrating on establishments of this method by delivering from researchers with high speciality to the CPR and new technology including automation has been under development with CPR researchers who are highly skilled in both engineering and biotechnology.